Continental Advisors’s Bausch Health BHC Stock Holding History

Continental Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,500	Closed	-$778K	–	163
2015 Q2	$778K	Buy	+3,500	New	+$776K	0.21%	107

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Continental Advisors's BHC Position: Q2 2022 in Review

Continental Advisors sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 23,000 shares — an estimated $526K sold.

Continental Advisors first reported a position in BHC in Q1 2016 and held it in 25 quarters. The position peaked at $4.07M in Q3 2018. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

Continental Advisors reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
Continental Advisors sold 23,000 Bausch Health shares in Q2 2022, an estimated $526K.
Continental Advisors first reported a position in Bausch Health in Q1 2016 and held it in 25 quarters.
Continental Advisors's Bausch Health position peaked at $4.07M in Q3 2018.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Continental Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.